APA

Saw R. P. M., Armstrong B. K., Mason R. S., Morton R. L., Shannon K. F., Spillane A. J., Stretch J. R. & Thompson J. F. (20150528). Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D). : BMC cancer.

Chicago

Saw Robyn P M, Armstrong Bruce K, Mason Rebecca S, Morton Rachael L, Shannon Kerwin F, Spillane Andrew J, Stretch Jonathan R and Thompson John F. 20150528. Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D). : BMC cancer.

Harvard

Saw R. P. M., Armstrong B. K., Mason R. S., Morton R. L., Shannon K. F., Spillane A. J., Stretch J. R. and Thompson J. F. (20150528). Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D). : BMC cancer.

MLA

Saw Robyn P M, Armstrong Bruce K, Mason Rebecca S, Morton Rachael L, Shannon Kerwin F, Spillane Andrew J, Stretch Jonathan R and Thompson John F. Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D). : BMC cancer. 20150528.